Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daya Darou is a leading Iranian pharmaceutical company specializing in the marketing, distribution, and sale of high-tech medicinal products. Established in 2004, the company focuses on providing the Iranian healthcare market with access to advanced therapies, particularly in the fields of oncology, hematology, and nephrology. Daya Darou serves as a strategic local partner for several global pharmaceutical manufacturers, managing the regulatory registration, importation, and specialized distribution of critical medications. The company operates a sophisticated logistics network, including cold chain capabilities, to ensure the integrity of biologics and other sensitive treatments. By bridging the gap between international innovation and local patient needs, Daya Darou plays a vital role in the Iranian specialty pharma landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Daya Darou.